Reduced Number of Platelets During Intra-Aortic Balloon Pumping Counterpulsation Predicts Higher Cardiovascular Mortality After Device Removal in Association with Systemic Inflammation
Authors:
- 31 January 2020
- journal article
- research article
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 61 (1) , 89-95
Abstract
Thrombocytopenia is a frequent complication in patients requiring intra-aortic balloon pumping (IABP) counterpulsation. However, its prognostic impact has not been fully addressed. The objective of this study is to evaluate the impact of the change in the platelet number during IABP use on the prognosis after device removal.This is a retrospective observational study. Patients in the intensive cardiac care unit at three Juntendo University hospitals who underwent percutaneous implantation of IABP with or without veno-arterial extracorporeal membrane oxygenation (V-A ECMO), since 2012-2016, were enrolled in the study (n = 439). Patients who died during mechanical circulatory support (n = 47) were excluded. We evaluated the prognostic impact of the ratio of platelet reduction from the baseline (% PLT reduction) during IABP use on cardiovascular mortality after device removal.The median and the range of follow-up period were 298 days and 0-1,869 days, respectively. Unadjusted Kaplan-Meier analysis demonstrated that patients with a higher % PLT reduction had higher cardiovascular (CV) mortality. An adjusted Cox proportional hazard analysis demonstrated that a 10% higher % PLT reduction was associated with higher cardiovascular (CV) mortality (Hazard ratio: 1.3, 95% Confidence interval: 1.1-1.6, P < 0.001). Moreover, % PLT reduction and the maximum C-reactive protein (CRP) level during IABP use were positively correlated (r = 0.326, P < 0.001).The reduced number of platelets during IABP use was associated with an increased risk of CV mortality.Keywords
This publication has 19 references indexed in Scilit:
- The Phospholipidomic Signatures of Human Blood Microparticles, Platelets and Platelet‐Derived Microparticles: a Comparative HILIC‐ESI–MS InvestigationLipids, 2014
- Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomesEuropean Heart Journal, 2014
- Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien© valves: A single center experienceCatheterization and Cardiovascular Interventions, 2013
- Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in miceBlood, 2013
- Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic ShockCirculation: Heart Failure, 2013
- Microparticles, Vascular Function, and AtherothrombosisCirculation Research, 2011
- Clinical Implications of Thrombocytopenia Among Patients Undergoing Intra‐aortic Balloon Pump Counterpulsation in the Coronary Care UnitClinical Cardiology, 2010
- Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])The American Journal of Cardiology, 2009
- Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST ElevationCirculation, 2001
- Recessive Inheritance of a Congenital Malformation SyndromeJAMA, 1968